Navigation Links
Georgia: Indian doctor's license cancelled

A 70-year-old Indian-American doctor’s licence has been suspended by the Medical Board of Georgia state for allegedly using insecticides to treat cancer patients // and prescribing unauthorised drugs.

The nine-member board took the unanimous decision at a meeting on Thursday.

The board's action came after a federal grand jury had accused Totada R Shanthaveerappa, a practitioner in Stockbridge, earlier this week, of using weed killer and insecticide to treat patients. The jury had returned an 87-count indictment accusing him of falsely billing insurance companies that he was using approved drugs.

In its order, the state board cited the case of a cancer patient treated by Shanthaveerappa in 2001. It said the 70-year-old doctor treated the patient with a chemotherapy drug called methotrexate in doses so high they posed "an unreasonable and significant risk to the patient who subsequently died from complications caused by the methotrexate".

The board said it had received a letter from Shanthaveerappa on Thursday acknowledging that he had treated patients with two drugs not approved for use in the United States and that he misbranded one of the drugs.

Prosecutors claim that Shanthaveerappa and his assistant, Dan Bartoli, injected numerous patients with unapproved and misbranded drugs, including Dinithrophenol, a weed killer and other insecticides. The two men also submitted false insurance claims, which disguised the types of drugs and treatments they were providing.

Shanthaveerappa has not been arrested. His lawyer Donaway said the doctor plans to plead not guilty when he appears in court on Tuesday.

Sources in the law enforcement agency said they expect him to surrender within the next few days.

Shanthaveerappa, who has been licensed to practice since 1972, can appeal the medical board's decision before a state administrative law judge or the state Supreme Court.

Shanthaveerappa runs the Integrated Medical Specialist clinic and its website says its goal is to use a combination of conventional and alternative therapies to cure cancer whenever possible, by combining the latest in conventional and alternative modalities for an unsurpassed multi-level attack against all cancer,' it says.

According to the website, the standard 2-3 week treatment will cost between $25,000 and $45,000, and maximum charges will not exceed $60,000 dollars for 3 to 6 weeks.


'"/>




Related medicine news :

1. Indian Prime Minister has successful Knee Replacement Surgery
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Indian Doctor granted US patent on organ regeneration
4. Heart attack kills one in every 10 Indians
5. Indian Cherry: Richest Source of Vitiamin C
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. An Indian Bride with signs of SARS
8. Are Indians aware of SARS ?
9. Indians Stay Away from Coke, Pepsi After Toxin Scare
10. Indian pharma industry upbeat on WTO drug deal
11. Indian Treatment for Iraqi Babies
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/17/2017)... ... 17, 2017 , ... For the first time, International Scholarship ... exhibit floor for the 2017 HIMSS Conference & Exhibition at the ... more than 40,000 healthcare industry professionals are expected at the conference, where they ...
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering ... Francis' goals for each and every seminar, session and class she offers. ... five different brainwave tools which help energize creativity, focus mental functions, enhance athletic ...
(Date:2/17/2017)... ... February 17, 2017 , ... Qualis ... a finalist in the 8th Annual DecisionHealth Platinum Awards in recognition of its ... Health’s work is recognized across multiple award categories, highlighting four of the organization’s ...
(Date:2/17/2017)... ... 2017 , ... Program will serve more than 5,000 kids ... Soccer Foundation announced today that they have awarded nine grants to expand the ... soccer mentoring program, teaches kids the fundamentals of soccer while striving to help ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... and focusing on all facets of clinical trial planning and management. Pharmica discussed ... engagement, and more. In addition, attendees stopping by Pharmica’s booth were able to ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... LOUIS , Feb. 17, 2017   FormFast ... has announced a new partnership with Engage , ... the United States . FormFast will serve as ... of Engage,s implementations with MEDITECH .  ... provides essential functionality to complement and enhance the electronic ...
(Date:2/17/2017)... February 17, 2017 On Thursday, ... 500 edged lower at the closing bell, while the ... the 20,000 benchmark. Moreover, five out of nine sectors ... consideration yesterday,s market sentiment, Stock-Callers.com assessed the following Medical ... PLC (NYSE: SNN ), ABIOMED Inc. (NASDAQ: ...
(Date:2/16/2017)... DUBLIN , Feb. 16, 2017 ... "Global Markets for Emerging Medical Device Technologies" report to ... ... heart valves, open procedures, general instruments, non-drug coated implantables, large ... have been in use over the last two to three ...
Breaking Medicine Technology: